FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Akorn Ethosuximide Capsules Recall

Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPhar…

Akorn, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Sep 12, 2018
Recall ID
D-1183-2018
Check your lot numberHow we source this data

Summary

Akorn recalled Ethosuximide Capsules starting Aug 24, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1183-2018 on Sep 12, 2018. Reason: Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.

Product description

Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01

Lot numbers, UPCs & expiration codes

Lots: 1165280100, 1165280101, EXP 3/2019

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1183-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 24, 2018
FDA report date
Sep 12, 2018
Quantity
23,788 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-1183-2018, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
80880
Address
1925 W Field Ct Ste 300
Code information
Lots: 1165280100, 1165280101, EXP 3/2019
Postal code
60045-4862
Report date
Sep 12, 2018
Product type
Drugs
Recall number
D-1183-2018
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
23,788 100-count bottles
Termination date
Nov 6, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 24, 2018
Initial firm notification
Letter
Center classification date
Sep 7, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1183-2018, published Sep 12, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls